look news india
US approves weight loss drug: Obesity is also called obesity. This is also a kind of disease which causes a lot of trouble to the people suffering from it. Now there is good news for people suffering from obesity. America has approved a weight loss medicine. It can also be launched in India soon.
Who is this medicine designed for?
This medicine is designed for patients suffering from sleep apnea. This disease is also known as OSA. The US Food and Drug Administration (FDA) has approved it for the first time as an anti-diabetes drug. It will be known as Zepbound (tirazeptide). This medication is approved to control obesity-related OSA in adults. It is also used for weight loss.
The price of the medicine has not been decided yet!
Moderate to severe OSA is currently treated using assisted breathing devices such as CPAP and Bi-PAP. If all approvals are received, we will launch this injection in India under the brand name Monjaro by 2025, said Zepbound manufacturer Aloys Lilly. The price of the medicine has not been decided yet.
